MEREDITH LEDUC: Open Payments
NPI 1366201071 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,391 in 288 payments from 32 companies in 2025. Trend: 2023 $0 · 2024 $2,197 · 2025 $8,391
Food & beverage: $6,602Travel & lodging: $1,666Education: $123
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 8 | $2,193 |
| ABBVIE INC. | 83 | $1,251 |
| Alexion Pharmaceuticals, Inc. | 18 | $677 |
| Lundbeck LLC | 15 | $364 |
| JAZZ PHARMACEUTICALS INC. | 10 | $362 |
| SK Life Science, Inc. | 13 | $323 |
| Eisai Inc. | 11 | $299 |
| Teva Pharmaceuticals USA, Inc. | 14 | $292 |
| Amgen Inc. | 9 | $265 |
| Neurocrine BioSciences, Inc. | 11 | $244 |
Products named: VNS Therapy, QULIPTA, ULTOMIRIS, EPIDIOLEX, VYEPTI, UBRELVY, Leqembi, INGREZZA.
Industry payments across IN — which companies pay providers there.
